AbbVie (ABBV) Stock Price, Quote, News & History | Benzinga

AbbVie Inc (ABBV) Stock Price, Quote, News & History

ABBVNYSE

Trade with Public

Trade with Public

$216.35

-4.88-2.21%

Last update: Jun 18, 3:26 PM

OverviewNews Earnings Events Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$221.37

Close

-

Volume / Avg.

3.93M / 6.42M

Day Range

$215.37 - $222.35

52 Wk Range

181.73 - 244.81

Market Cap

$382.67B

P/E Ratio

108.45

Dividend Yield

3.13%

Exchange

NYSE

RSI

48

Short Interest

1.46%

Days to Cover

4.27

Recent Abbvie Inc News

AbbVie, Devon Energy And More On CNBC's 'Final Trades'

On CNBC's Halftime Report, experts picked U.S. 10 Year Treasury, AbbVie, and Devon Energy as top trades. AbbVie sees growth due to expanded label.

Avi Kapoor

Morgan Stanley, Shake Shack, Cboe Global Markets And A Health Care Stock On CNBC's 'Final Trades'

Joshua Brown is still bullish on Shake Shack, while Malcolm Ethridge recommends Morgan Stanley and Jim Lebenthal picks AbbVie Inc. as their final trades.

Avi Kapoor

AbbVie, Oracle, Apple And More On CNBC's 'Final Trades'

Bryn Talkington picks AbbVie as final trade with $232 price target. Bill Baruch chooses Entegris . Oracle and Apple also feature.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

21.22B

Investing Cash Flow (TTM)

-6.48B

Financing Cash Flow (TTM)

-10.55B

Free Cash Flow (TTM)

19.98B

Capital Expenditure (TTM)

-1.24B

Net Change in Cash (TTM)

4.20B

Analyst Trends and Forecast

2

Jan

6

1

Feb

7

Apr

4

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$454.33B

PE Ratio (TTM)

108.45

PE Ratio (FWD)

15.53

PEG Ratio (TTM)

0.61

PS Ratio (TTM)

6.25

PB Ratio (TTM)

-

Earnings Yield % (TTM)

0.92%

Earnings Yield % (FWD)

6.44%

EV / EBITDA (TTM)

26.85

Price / EBITDA (TTM)

23.19

Price / Free Cash Flow (TTM)

19.64

Book Value / Share

-$3.77

Company Debt

Total Debt

$72.86B

LT Debt

$64.53B

LT Debt Issuance (TTM)

$7.99B

LT Debt Repayment (TTM)

-$3.77B

Total Cash

$9.39B

Debt to Equity

-

Issuance of Debt (TTM)

$4.22B

Repayment of Debt (TTM)

-$9.07B

Key Statistics

Open

$221.37

Close

-

Volume / Avg.

3.93M / 6.42M

Day Range

$215.37 - $222.35

52 Wk Range

181.73 - 244.81

Market Cap

$382.67B

P/E Ratio

108.45

Dividend Yield

3.13%

Exchange

NYSE

RSI

48

Short Interest

1.46%

Days to Cover

4.27

About

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy AbbVie (ABBV) stock?

A

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AbbVie (ABBV) competitors?

A

There are no as such competitors for AbbVie.

Q

What is the forecast, or price target, for AbbVie (ABBV) stock?

A

AbbVie has a consensus price target of $238.97.

Q

What is the current price for AbbVie (ABBV)?

A

The stock price for AbbVie (NYSE: ABBV) is $216.35 last updated June 18, 2026 at 3:26 PM EDT.

Q

Does AbbVie (ABBV) pay a dividend?

A

There are no upcoming dividends for AbbVie.

Q

When is AbbVie (NYSE:ABBV) reporting earnings?

A

AbbVie does not have any upcoming earnings scheduled.

Q

Is AbbVie (ABBV) going to split?

A

There is no upcoming split for AbbVie.

Q

What sector and industry does AbbVie (ABBV) operate in?

A

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.